Q2 2023 · 13F-HR
First Light Asset Management, LLCholdings as filed
Filed 2023-08-14 · accession 0001387131-23-009775
$1.28B
Reported value
79
Positions
2023-06-30
Period end
Holdings as filed
| CUSIP | Ticker | Issuer | Value | % port. | Shares | Class | Voting |
|---|---|---|---|---|---|---|---|
| 75615P103 | — | REATA PHARMACEUTICALS INC | $146.0M | 11.4% | 1,432,208 | Common | SOLE |
| G72800108 | PRTA | PROTHENA CORPORATION PLC | $102.4M | 8.03% | 1,500,129 | Common | SOLE |
| 04963C209 | ATRC | ATRICURE INC | $72.1M | 5.65% | 1,461,635 | Common | SOLE |
| 607525102 | MODNEUR | MODEL N INC | $66.0M | 5.17% | 1,865,525 | Common | SOLE |
| 825704109 | SIBN | SI-BONE INC | $57.1M | 4.47% | 2,114,829 | Common | SOLE |
| 02081G201 | ATEC | ALPHATEC HOLDINGS INC | $53.4M | 4.19% | 2,971,877 | Common | SOLE |
| 48576A100 | — | KARUNA THERAPEUTICS INC | $45.3M | 3.55% | 208,746 | Common | SOLE |
| 68752M108 | OFIX | ORTHOFIX MED INC | $44.4M | 3.48% | 2,459,129 | Common | SOLE |
| 088786108 | BCYC | BICYCLE THERAPEUTICS PLC | $44.4M | 3.48% | 1,739,449 | Common | SOLE |
| 64049M209 | NEO | NEOGENOMICS INC | $43.3M | 3.39% | 2,692,057 | Common | SOLE |
| 69913P105 | FNAUSD | PARAGON 28 INC | $36.5M | 2.86% | 2,057,307 | Common | SOLE |
| 729139105 | PLRX | PLIANT THERAPEUTICS INC | $32.8M | 2.57% | 1,810,176 | Common | SOLE |
| 42225T107 | HCAT | HEALTH CATALYST INC | $31.8M | 2.49% | 2,540,959 | Common | SOLE |
| 89377M109 | TMDX | TRANSMEDICS GROUP INC | $31.7M | 2.48% | 377,464 | Common | SOLE |
| 22663K107 | CRNX | CRINETICS PHARMACEUTICALS INC | $28.1M | 2.20% | 1,557,222 | Common | SOLE |
| 90400D108 | RARE | ULTRAGENYX PHARMACEUTICAL INC | $27.2M | 2.13% | 589,963 | Common | SOLE |
| 68401U204 | OPRX | OPTIMIZERX CORP | $26.7M | 2.10% | 1,871,799 | Common | SOLE |
| 71377E105 | PFMTUSD | PERFORMANT FINANCIAL CORPORATION | $25.0M | 1.96% | 9,249,683 | Common | SOLE |
| 68213N109 | OMCL | OMNICELL INC | $23.7M | 1.86% | 321,664 | Common | SOLE |
| 98943L107 | ZNTL | ZENTALIS PHARMACEUTICALS INC | $21.4M | 1.68% | 757,835 | Common | SOLE |
| 40637H109 | HALO | HALOZYME THERAPEUTICS INC | $21.1M | 1.65% | 584,248 | Common | SOLE |
| 759910102 | KRMD | KORU MEDICAL SYSTEMS INC | $18.3M | 1.43% | 5,299,639 | Common | SOLE |
| 05463X106 | AXGN | AXOGEN INC | $18.0M | 1.41% | 1,973,699 | Common | SOLE |
| 87357P100 | TCMD | TACTILE SYSTEMS TECHNOLOGY INC | $17.7M | 1.39% | 711,345 | Common | SOLE |
| 872381108 | TELA | TELA BIO INC | $17.5M | 1.37% | 1,725,500 | Common | SOLE |
| 000380204 | — | ABCAM PLC | $17.4M | 1.36% | 710,745 | Common | SOLE |
| 492327101 | KROS | KEROS THERAPEUTICS INC | $16.7M | 1.31% | 416,830 | Common | SOLE |
| 05465P101 | AXNX* | AXONICS MODULATION TECHNOLOGIES | $15.8M | 1.24% | 312,786 | Common | SOLE |
| 75629F109 | RAH | SOCIETAL CDMO INC | $14.7M | 1.16% | 13,405,030 | Common | SOLE |
| 875372203 | TNDM | TANDEM DIABETES CARE INC | $14.7M | 1.16% | 600,767 | Common | SOLE |
| 690145107 | OMGBP | OUTSET MEDICAL INC | $13.9M | 1.09% | 637,422 | Common | SOLE |
| 457669307 | INSM | INSMED INC | $13.6M | 1.07% | 645,686 | Common | SOLE |
| 68752L100 | KIDS | ORTHOPEDIATRICS CORP | $13.1M | 1.03% | 298,976 | Common | SOLE |
| 98420N105 | XENE | XENON PHARMACEUTICALS | $13.0M | 1.02% | 338,646 | Common | SOLE |
| 501147102 | KRYS | KRYSTAL BIOTECH INC | $11.9M | 0.93% | 101,259 | Common | SOLE |
| 232109108 | CUTREUR | CUTERA INC | $8.6M | 0.68% | 570,729 | Common | SOLE |
| 57777K106 | MXCT | MAXCYTE INC | $8.5M | 0.67% | 1,857,566 | Common | SOLE |
| 40131M109 | GH | GUARDANT HEALTH | $7.1M | 0.55% | 197,704 | Common | SOLE |
| 032724106 | ANAB | ANAPTYS BIO INC | $6.6M | 0.51% | 322,208 | Common | SOLE |
| 372303206 | GMAB | GENMAB AS | $6.0M | 0.47% | 158,509 | Common | SOLE |
| 835431107 | — | SONENDO INC | $5.7M | 0.45% | 4,185,619 | Common | SOLE |
| 09061G101 | BMRN | BIOMARIN PHARMACEUTICAL INC | $5.3M | 0.41% | 60,654 | Common | SOLE |
| 717081103 | PFE | PFIZER INC | $5.1M | 0.40% | 140,235 | Common | SOLE |
| 60471P108 | — | MIROMATRIX MEDICAL INC | $3.9M | 0.31% | 2,225,740 | Common | SOLE |
| T9224W109 | STVN | STEVANATO GROUP SPA | $3.7M | 0.29% | 114,276 | Common | SOLE |
| 09073M104 | TECH | BIO TECHNE CORP | $2.7M | 0.21% | 33,178 | Common | SOLE |
| 14843C105 | CSTL | CASTLE BIOSCIENCES INC | $2.2M | 0.17% | 160,126 | Common | SOLE |
| 75974E103 | — | RENEO PHARMACEUTICALS INC | $1.6M | 0.13% | 250,000 | Common | SOLE |
| 829214105 | SLP | SIMULATIONS PLUS INC | $1.5M | 0.12% | 35,355 | Common | SOLE |
| 83175M205 | SNN | SMITH & NEPHEW PLC SPONSORED ADR | $487,330 | 0.04% | 15,111 | Common | SOLE |
| 358029106 | FMS | FRESENIUS MEDICAL CARE AG & CO SPONSORED ADR | $466,396 | 0.04% | 19,490 | Common | SOLE |
| 194014502 | ENOV | ENOVIS CORP | $461,856 | 0.04% | 7,203 | Common | SOLE |
| 66987V109 | NVS | NOVARTIS AG-SPONSORED ADR | $416,052 | 0.03% | 4,123 | Common | SOLE |
| 80105N105 | SNY | SANOFI-SYNTHELABO | $415,623 | 0.03% | 7,711 | Common | SOLE |
| 874060205 | TAK | TAKEDA PHARMACEUTICAL CO | $402,647 | 0.03% | 25,630 | Common | SOLE |
| 444859102 | HUM | HUMANA INC | $397,051 | 0.03% | 888 | Common | SOLE |
| 036752103 | ELV | ELEVANCE HEALTH INC | $393,641 | 0.03% | 886 | Common | SOLE |
| 15135B101 | CNC | CENTENE CORPORATION | $372,391 | 0.03% | 5,521 | Common | SOLE |
| G5960L103 | MDT | MEDTRONIC PLC | $368,963 | 0.03% | 4,188 | Common | SOLE |
| 37733W204 | GSK | GLAXOSMITHKLINE PLC | $358,467 | 0.03% | 10,058 | Common | SOLE |
| 478160104 | JNJ | JOHNSON & JOHNSON | $357,689 | 0.03% | 2,161 | Common | SOLE |
| 219798105 | QDEL | QUIDEL CORP | $352,735 | 0.03% | 4,257 | Common | SOLE |
| 30161Q104 | EXEL | EXELIXIS INC | $352,484 | 0.03% | 18,445 | Common | SOLE |
| 072730302 | BAYRY | BAYER AG SPONSORED ADR | $352,065 | 0.03% | 25,475 | Common | SOLE |
| 40412C101 | HCA | HCA HOLDINGS INC | $352,037 | 0.03% | 1,160 | Common | SOLE |
| 375558103 | GILD | GILEAD SCIENCES INC | $348,819 | 0.03% | 4,526 | Common | SOLE |
| 92556V106 | VTRS | VIATRIS INC | $329,440 | 0.03% | 33,010 | Common | SOLE |
| 24906P109 | XRAY | DENTSPLY SIRONA INC | $329,285 | 0.03% | 8,228 | Common | SOLE |
| 09062X103 | BIIB | BIOGEN INC | $312,196 | 0.02% | 1,096 | Common | SOLE |
| N72482123 | — | QIAGEN N.V. | $311,247 | 0.02% | 6,912 | Common | SOLE |
| 703395103 | PDCOEUR | PATTERSON COMPANIES INC | $308,121 | 0.02% | 9,264 | Common | SOLE |
| 05352A100 | AVTR | AVANTOR INC | $299,802 | 0.02% | 14,596 | Common | SOLE |
| 457985208 | IART | INTEGRA LIFESCIENCES HOLDINGS CORP | $298,645 | 0.02% | 7,261 | Common | SOLE |
| 91307C102 | UTHR | UNITED THERAPEUTICS CORP DEL | $296,909 | 0.02% | 1,345 | Common | SOLE |
| 50540R409 | LSI | LABORATORY CORPORATION OF AMERICAN HOLDINGS | $293,940 | 0.02% | 1,218 | Common | SOLE |
| 01021F109 | — | AKUMIN INC | $283,518 | 0.02% | 1,575,098 | Common | SOLE |
| 68622V106 | OGN | ORGANON & CO | $264,620 | 0.02% | 12,716 | Common | SOLE |
| 714046109 | RVTY | REVVITY INC | $264,070 | 0.02% | 2,223 | Common | SOLE |
| 87166B102 | — | SYNEOS HEALTH INC CLASS A | $241,715 | 0.02% | 5,736 | Common | SOLE |
Source: SEC EDGAR · raw 13F holdings as filed. The Class column shows the option type when reported (Put/Call) or Common when the issuer's equity is held directly. 13F discloses long positions only.